Literature DB >> 8636705

Establishment and characterization of a carrier cell culture producing high titres of polyoma JC virus.

S Nukuzuma1, Y Yogo, J Guo, C Nukuzuma, S Itoh, T Shinohara, K Nagashima.   

Abstract

This report concerns a carrier cell culture (designated JCI) infected persistently with JC virus (JCV). Immunostaining with an anti-JCV antiserum revealed that JCI was a carrier culture in which only a small fraction of the cells (approximately 1.5%) produced the virus. The JCV titre was increased strikingly by incubating confluent JCI cells for 4-6 days in medium containing a low concentration of fetal bovine serum (2%). Viral genomes cloned from the persistently infected JCI cells were heterogeneous with respect to size, but most clones had an alteration of the same regulatory region (designated CR-JCI). Transfection experiments with a chimeric JCV DNA (Mad-1/CR-JCI), in which the regulatory region was CR-JCI and the other region was derived from an infectious JCV (Mad-1) DNA, showed that CR-JCI was less efficient in inducing viral growth than the regulatory regions of IMR-32-adapted JCVs. The transfected cells could be readily subcultured, and they continued to produce JCV. It is concluded that a decrease in the activity of the JCV regulatory region is of importance for the maintenance of the carrier state of JCI cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8636705     DOI: 10.1002/jmv.1890470413

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  14 in total

1.  Analysis of capsid formation of human polyomavirus JC (Tokyo-1 strain) by a eukaryotic expression system: splicing of late RNAs, translation and nuclear transport of major capsid protein VP1, and capsid assembly.

Authors:  Y Shishido-Hara; Y Hara; T Larson; K Yasui; K Nagashima; G L Stoner
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

Review 2.  The role of sialic acid in human polyomavirus infections.

Authors:  Gretchen V Gee; Aisling S Dugan; Natia Tsomaia; Dale F Mierke; Walter J Atwood
Journal:  Glycoconj J       Date:  2006-02       Impact factor: 2.916

3.  Oligosaccharides as receptors for JC virus.

Authors:  Rika Komagome; Hirofumi Sawa; Takashi Suzuki; Yasuo Suzuki; Shinya Tanaka; Walter J Atwood; Kazuo Nagashima
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

4.  JC virus agnoprotein colocalizes with tubulin.

Authors:  Shuichi Endo; Yuki Okada; Yasuko Orba; Hiroshi Nishihara; Shinya Tanaka; Kazuo Nagashima; Hirofumi Sawa
Journal:  J Neurovirol       Date:  2003       Impact factor: 2.643

5.  Detection of human JCPyV and BKPyV in diffuse large B-cell lymphoma of the GI tract.

Authors:  C E Tseng; C M Yeh; C Y Fang; J Shay; P L Chen; M C Lin; D Chang; M Wang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-11-21       Impact factor: 3.267

6.  Distribution and function of JCV agnoprotein.

Authors:  Y Okada; S Endo; H Takahashi; H Sawa; T Umemura; K Nagashima
Journal:  J Neurovirol       Date:  2001-08       Impact factor: 2.643

7.  Large T antigen promotes JC virus replication in G2-arrested cells by inducing ATM- and ATR-mediated G2 checkpoint signaling.

Authors:  Yasuko Orba; Tadaki Suzuki; Yoshinori Makino; Kanako Kubota; Shinya Tanaka; Takashi Kimura; Hirofumi Sawa
Journal:  J Biol Chem       Date:  2009-11-10       Impact factor: 5.157

8.  Archetype JC virus efficiently replicates in COS-7 cells, simian cells constitutively expressing simian virus 40 T antigen.

Authors:  K Hara; C Sugimoto; T Kitamura; N Aoki; F Taguchi; Y Yogo
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

9.  The human polyoma JC virus agnoprotein acts as a viroporin.

Authors:  Tadaki Suzuki; Yasuko Orba; Yuki Okada; Yuji Sunden; Takashi Kimura; Shinya Tanaka; Kazuo Nagashima; William W Hall; Hirofumi Sawa
Journal:  PLoS Pathog       Date:  2010-03-12       Impact factor: 6.823

10.  Inhibition of virus production in JC virus-infected cells by postinfection RNA interference.

Authors:  Yasuko Orba; Hirofumi Sawa; Hiroshi Iwata; Shinya Tanaka; Kazuo Nagashima
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.